Jie Shen
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 7
- Spectroscopy top 5%
- Molecular Sensors and Ion Detection 5
- Organic Chemistry top 5%
- Supramolecular Chemistry and Complexes 7
- Pharmaceutical Science top 10%
- Materials Chemistry top 10%
- Crystallization and Solubility Studies 7
- Luminescence and Fluorescent Materials 6
-
- Nanoplatforms for cancer theranostics 8
-
- Crystallography and molecular interactions 7
-
- RNA Interference and Gene Delivery 4
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Biomaterials (3 papers)Chemical Communications (2 papers)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Jie Shen
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Biomaterials 394
- Spectroscopy 252
- Organic Chemistry 338
- Pharmaceutical Science 56
- Materials Chemistry 415
Countries citing papers authored by Jie Shen
This map shows the geographic impact of Jie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Shen more than expected).
Fields of papers citing papers by Jie Shen
This network shows the impact of papers produced by Jie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Shen. The network helps show where Jie Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 23 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 100 | |
| 14 | 2019 | 14 | |
| 15 | 2019 | 16 | |
| 16 | 2017 | 70 | |
| 17 | 2015 | 20 | |
| 18 | 2014 | 71 | |
| 19 | 2012 | 5 | |
| 20 | Study on the treatment of the patients with malignant pleural effusion by DC-CIK cells combined with IL-2. | 2009 | 1 |
About Jie Shen
Jie Shen is a scholar working on Physical and Theoretical Chemistry, Biomaterials and Spectroscopy, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Crystallization and Solubility Studies (7 papers), Crystallography and molecular interactions (7 papers), Supramolecular Chemistry and Complexes (7 papers), Luminescence and Fluorescent Materials (6 papers), Molecular Sensors and Ion Detection (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (394 citations), Spectroscopy (252 citations) and Organic Chemistry (338 citations). Jie Shen has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Guping Tang, Guocan Yu, Qiwen Wang, Feihe Huang, Jiong Zhou, Qinglian Hu, Paul K. Chu, Dan Wu, Ying Gao and Xiu-Rong Hu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biomaterials and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.